Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › HI › Wailuku › NPI 1528042561
Clinic

Community Clinic of Maui, INC.

Community Clinic of Maui, INC. was paid $21.69M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 59% of everything it billed.

33Billing provider infoCOMMUNITY CLINIC OF MAUI, INC.
WAILUKU, HI 96793
33aNPI1528042561assigned 12/02/2005
28Total paid$21.69M
24GClaims207,251
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Federally Qualified Health Center (FQHC) providers in Hawaii

Rank by total paid#3 of 31
Median peer was paid$614K
This provider vs. median35×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201830,125$3.01M
201925,466$2.88M
202017,717$1.92M
202120,320$2.41M
202222,927$2.90M
202325,049$4.50M
2024incomplete65,647$4.07M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 59% 53,841 45,697 $12.83M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 24% 19,279 17,093 $5.16M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 4.6% 3,861 3,459 $997K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3.3% 2,849 2,615 $718K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2.2% 1,747 1,611 $481K
G0467 Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit 1.7% 6,399 5,241 $366K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.5% 1,946 1,658 $319K
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient <1% 985 696 $197K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 465 434 $138K
90837 Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient <1% 368 196 $123K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 348 321 $78K
90834 Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient <1% 319 227 $75K
90 more codes
G2025 Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only <1% 190 $54K
97803 <1% 119 $31K
99204 Doctor's office visit, new patient (more involved) <1% 101 $26K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 137 $23K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 12,425 $18K
81025 <1% 877 $11K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,099 $7K
97802 <1% 28 $7K
99215 Doctor's office visit, returning patient (complex) <1% 17 $3K
G0470 Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit <1% 31 $3K
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination <1% 58 $3K
81002 <1% 8,979 $2K
90791 Psychiatric diagnostic evaluation <1% 14 $2K
82962 <1% 3,498 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,002 $2K
90670 <1% 1,773 $2K
1000F <1% 4,844 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 35 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 1,404 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 12 $1K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 5,991 $1K
90472 Immunization administration, each additional vaccine (list separately) <1% 1,322 $921.34
3008F <1% 5,245 $819.91
2001F <1% 8,228 $819.90
90461 <1% 3,125 $615.97
92551 <1% 4,687 $541.20
99177 <1% 2,416 $288.74
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 381 $120.47
83026 <1% 1,094 $46.44
99173 <1% 4,570 $31.32
86580 <1% 82 $13.36
81000 <1% 4,171 $13.13
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 14 $1.96
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 155 $0.72
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 307 $0.39
J7609 Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg <1% 438 $0.19
1111F 0% 28 $0.00
90686 0% 1,182 $0.00
1126F 0% 546 $0.00
3079F 0% 778 $0.00
36415 Collection of venous blood by venipuncture 0% 159 $0.00
3044F 0% 349 $0.00
3074F 0% 5,178 $0.00
2000F 0% 6,826 $0.00
90656 0% 1,859 $0.00
36416 0% 150 $0.00
1220F 0% 2,630 $0.00
4000F 0% 347 $0.00
90698 0% 438 $0.00
1036F 0% 161 $0.00
90744 0% 92 $0.00
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 0% 27 $0.00
3075F 0% 303 $0.00
90480 0% 47 $0.00
3080F 0% 181 $0.00
1125F 0% 17 $0.00
90688 0% 14 $0.00
90677 0% 179 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 14 $0.00
90716 0% 25 $0.00
H0033 Oral medication administration, direct observation 0% 16 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 52 $0.00
90620 0% 15 $0.00
96127 0% 20 $0.00
87807 0% 14 $0.00
90651 0% 12 $0.00
90723 0% 47 $0.00
0134A 0% 13 $0.00
3078F 0% 4,663 $0.00
1159F 0% 2,634 $0.00
1160F 0% 2,631 $0.00
90648 0% 138 $0.00
90655 0% 161 $0.00
90633 0% 444 $0.00
3077F 0% 403 $0.00
99442 0% 72 $0.00
90681 0% 215 $0.00
91313 0% 13 $0.00
90715 0% 119 $0.00
90710 0% 45 $0.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 0% 199 $0.00
2028F 0% 137 $0.00
99188 0% 75 $0.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 57 $0.00
3046F 0% 40 $0.00
83655 0% 12 $0.00
90473 0% 129 $0.00
90649 0% 40 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 12 $0.00
3210F 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVAZ, JOHN (CHIEF EXECUTIVE OFFICER)